Abstract
Inflammatory bowel diseases, including Crohn’s Disease and Ulcerative Colitis, result from a dysregulated inflammatory response to environmental factors in genetically predisposed individuals. The list of genetic factors involved in the development of these diseases has considerably increased in last years. However, recently, new promising insights on inflammatory bowel diseases have been produced by studies on microRNAs. MicroRNAs are small non coding RNA molecules, that play a pivotal role in gene expression and regulation. They are involved in many biological processes, such as cellular proliferation and differentiation, signal transduction and, more recently, they have been recognized as also having a role in the innate and adaptative response. In this review we give an overview on the role of microRNAs in the pathogenesis of inflammatory bowel diseases.
Keywords: Crohn’s disease (CD), gene expression, genetic variability, inflammatory bowel diseases (IBD), microRNAs, susceptibility, ulcerative Colitis (UC).
Graphical Abstract
MicroRNA
Title:Advances in Exploring the Role of Micrornas in Inflammatory Bowel Disease
Volume: 5 Issue: 1
Author(s): Cinzia Ciccacci*, Cristina Politi, Giuseppe Novelli and Paola Borgiani
Affiliation:
- Department of Biomedicine and Prevention, Section of Genetics, School of Medicine, University of Rome “Tor Vergata”, Rome, Italy.,Italy
Keywords: Crohn’s disease (CD), gene expression, genetic variability, inflammatory bowel diseases (IBD), microRNAs, susceptibility, ulcerative Colitis (UC).
Abstract: Inflammatory bowel diseases, including Crohn’s Disease and Ulcerative Colitis, result from a dysregulated inflammatory response to environmental factors in genetically predisposed individuals. The list of genetic factors involved in the development of these diseases has considerably increased in last years. However, recently, new promising insights on inflammatory bowel diseases have been produced by studies on microRNAs. MicroRNAs are small non coding RNA molecules, that play a pivotal role in gene expression and regulation. They are involved in many biological processes, such as cellular proliferation and differentiation, signal transduction and, more recently, they have been recognized as also having a role in the innate and adaptative response. In this review we give an overview on the role of microRNAs in the pathogenesis of inflammatory bowel diseases.
Export Options
About this article
Cite this article as:
Ciccacci Cinzia*, Politi Cristina, Novelli Giuseppe and Borgiani Paola, Advances in Exploring the Role of Micrornas in Inflammatory Bowel Disease, MicroRNA 2016; 5 (1) . https://dx.doi.org/10.2174/2211536605666160111124812
DOI https://dx.doi.org/10.2174/2211536605666160111124812 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Engineering Nanomedicines to Overcome Multidrug Resistance in Cancer Therapy
Current Medicinal Chemistry Positron Emission Tomography for Neck Evaluation Following Definitive Treatment with Chemoradiotherapy for Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
Reviews on Recent Clinical Trials Inhibitors of the Hedgehog Signal Transduction Pathway
Current Cancer Therapy Reviews Meet Our Co-Editor Prof. Dr. Xiaofeng Charles Zhou
MicroRNA Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma:A Systematic Review
Current Genomics Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment
Current Cancer Drug Targets Anticancer Activity of Organogallium(III) Complexes in Colon Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry MRI Evaluation Using DWI and T2WI of Residual Lymph Nodes in patients Affected by Head and Neck Squamous Cell Carcinoma Treated with Chemo-Radiotherapy
Current Medical Imaging Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Current Protein & Peptide Science Computational Evaluation and In Vitro Validation of New Epidermal Growth Factor Receptor Inhibitors
Current Topics in Medicinal Chemistry Protein Biomarkers in Cancers of the Digestive Tract - a Step Towards Personalized Medicine
Current Proteomics Management of Locally Advanced Cancer Cervix an Indian Perspective
Reviews on Recent Clinical Trials MicroRNAs and Lung Cancer: New Oncogenes and Tumor Suppressors, New Prognostic Factors and Potential Therapeutic Targets
Current Medicinal Chemistry Immunomodulatory Lactoferrin in the Regulation of Apoptosis Modulatory Proteins in Cancer
Protein & Peptide Letters Extracellular Targeting of Synthetic Therapeutic Nucleic Acid Formulations
Current Gene Therapy Novel Chemotherapeutic Agents - The Contribution of Scorpionates
Current Medicinal Chemistry Anti-diabetic Drug Metformin: Challenges and Perspectives for Cancer Therapy
Current Cancer Drug Targets Flavonoids in Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry New Molecular Targets in the Treatment of NSCLC
Current Pharmaceutical Design